The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides
Open accessAbstract
Extensive research has been conducted on the development of three groups of naturally occurring antimicrobials as novel alternatives to antibiotics: bacteriophages (phages), bacterial cell wall hydrolases (BCWH), and antimicrobial peptides (AMP). Phage therapies are highly efficient, highly specific, and relatively cost-effective. However, precautions have to be taken in the selection of phage candidates for therapeutic applications as some phages may encode toxins and others may, when integrated into host bacterial genome and converted to prophages in a lysogenic cycle, lead to bacterial immunity and altered virulence. BCWH are divided into three groups: lysozymes, autolysins, and virolysins. Among them, virolysins are the most promising candidates as they are highly specific and have the capability to rapidly lyse antibiotic-resistant bacteria on a generally species-specific basis. Finally, AMP are a family of natural proteins produced by eukaryotic and prokaryotic organisms or encoded by phages. AMP are of vast diversity in term of size, structure, mode of action, and specificity and have a high potential for clinical therapeutic applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phages and the Evolution of Bacterial Pathogens: from Genomic Rearrangements to Lysogenic Conversion
Brüssow, H., Canchaya, C., & Hardt, W.-D. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.3.560-602.2004 · Cited by 1,725
Bacteriocins of lactic acid bacteria
Klaenhammer, T. R. (1988) · Biochimie · doi:10.1016/0300-9084(88)90206-4 · Cited by 1,539
Bacteriocins: Evolution, Ecology, and Application
Riley, M. A., & Wertz, J. E. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.161024 · Cited by 1,236
Antimicrobial peptides: premises and promises
Reddy, K. V. R., Yedery, R. D., & Aranha, C. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.09.005 · Cited by 1,068
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
MARR, A., GOODERHAM, W., & HANCOCK, R. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.006 · Cited by 1,051
LL-37, the only human member of the cathelicidin family of antimicrobial peptides
Dürr, U. H. N., Sudheendra, U. S., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.030 · Cited by 1,049
Miller, E. S., Kutter, E., Mosig, G., Arisaka, F., Kunisawa, T., & Rüger, W. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.1.86-156.2003 · Cited by 826
Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils
Turner, J., Cho, Y., Dinh, N.-N., Waring, A. J., & Lehrer, R. I. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2206 · Cited by 798
Biosynthesis and Mode of Action of Lantibiotics
Chatterjee, C., Paul, M., Xie, L., & van der Donk, W. A. (2005) · Chemical Reviews · doi:10.1021/cr030105v · Cited by 718
Lipid II as a target for antibiotics
Breukink, E., & de Kruijff, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2004 · Cited by 701
A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs
Gordon, Y. J., Romanowski, E. G., & McDermott, A. M. (2005) · Current Eye Research · doi:10.1080/02713680590968637 · Cited by 697
A bacteriolytic agent that detects and kills Bacillus anthracis
Schuch, R., Nelson, D., & Fischetti, V. A. (2002) · Nature · doi:10.1038/nature01026 · Cited by 656
Heilborn, J. D., Nilsson, M. F., Sørensen, O., Ståhle-Bäckdahl, M., Kratz, G., Weber, G., & Borregaard, N. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12069.x · Cited by 572
Pazgier, M., Hoover, D. M., Yang, D., Lu, W., & Lubkowski, J. (2006) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-005-5540-2 · Cited by 514
Long-circulating bacteriophage as antibacterial agents.
Merril, C. R., Biswas, B., Carlton, R., Jensen, N. C., Creed, G. J., Zullo, S., & Adhya, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3188 · Cited by 512
An Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II
Hasper, H. E., Kramer, N. E., Smith, J. L., Hillman, J. D., Zachariah, C., Kuipers, O. P., de Kruijff, B., & Breukink, E. (2006) · Science · doi:10.1126/science.1129818 · Cited by 501
Bera, A., Herbert, S., Jakob, A., Vollmer, W., & Götz, F. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04446.x · Cited by 481
Veterinary use and antibiotic resistance
Teuber, M. (2001) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00241-1 · Cited by 476
Salton, M. R. J. (1964) · Rabindra Nath Tagore Medical College, Udaipur · Cited by 452
Straus, S. K., & Hancock, R. E. W. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.009 · Cited by 446
Antimicrobial Properties of Lysozyme in Relation to Foodborne Vegetative Bacteria
Masschalck, B., & Michiels, C. W. (2003) · Critical Reviews in Microbiology · doi:10.1080/713610448 · Cited by 442
Phages will out: strategies of host cell lysis
Young, R., Wang, I.-N., & Roof, W. D. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01705-4 · Cited by 433
Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases
Matsuzaki, S., Rashel, M., Uchiyama, J., Sakurai, S., Ujihara, T., Kuroda, M., Imai, S., Ikeuchi, M., Tani, T., Fujieda, M., et al. (2005) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-005-0408-9 · Cited by 409
Bacteriophage lytic enzymes: novel anti-infectives
Fischetti, V. A. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.08.007 · Cited by 400
Salivary Proteins as a Defense Against Dietary Tannins
Shimada, T. (2006) · Journal of Chemical Ecology · doi:10.1007/s10886-006-9077-0 · Cited by 386
The prospect for bacteriophage therapy in Western medicine
Merril, C. R., Scholl, D., & Adhya, S. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1111 · Cited by 367
Schneider, J. J., Unholzer, A., Schaller, M., Schäfer-Korting, M., & Korting, H. C. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0657-1 · Cited by 366
The Control of Experimental Escherichia coli Diarrhoea in Calves by Means of Bacteriophages
Smith, H. W., Huggins, M. B., & Shaw, K. M. (1987) · Microbiology · doi:10.1099/00221287-133-5-1111 · Cited by 365
The human beta-defensin-3, an antibacterial peptide with multiple biological functions
Dhople, V., Krukemeyer, A., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.07.007 · Cited by 355
Frohm Nilsson, M., Sandstedt, B., Sørensen, O., Weber, G., Borregaard, N., & Ståhle-Bäckdahl, M. (1999) · Infection and Immunity · doi:10.1128/iai.67.5.2561-2566.1999 · Cited by 351
Genetic evidence that antibacterial activity of lysozyme is independent of its catalytic function
Ibrahim, H. R., Matsuzaki, T., & Aoki, T. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02872-1 · Cited by 350
Frequency of morphological phage descriptions in the year 2000
Ackermann, H.-W. (2001) · Archives of Virology · doi:10.1007/s007050170120 · Cited by 340
Antimicrobial peptides: New candidates in the fight against bacterial infections
Toke, O. (2005) · Peptide Science · doi:10.1002/bip.20286 · Cited by 322
Phage therapy: Facts and fiction
Skurnik, M., & Strauch, E. (2006) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2005.09.002 · Cited by 296
Structure and morphogenesis of bacteriophage T4
Leiman, P. G., Kanamaru, S., Mesyanzhinov, V. V., Arisaka, F., & Rossmann, M. G. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3072-1 · Cited by 269
Immunomodulatory Properties of Defensins and Cathelicidins
Bowdish, D. M. E., Davidson, D. J., & Hancock, R. E. W. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-29916-5_2 · Cited by 269
Multifunctional antimicrobial peptides: therapeutic targets in several human diseases
Zaiou, M. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0143-4 · Cited by 236
Fimland, G., Johnsen, L., Dalhus, B., & Nissen‐Meyer, J. (2005) · Journal of Peptide Science · doi:10.1002/psc.699 · Cited by 227
Lohner, K., & Blondelle, S. (2005) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207053764576 · Cited by 222
Dissection of Antibacterial and Toxic Activity of Melittin
Asthana, N., Yadav, S. P., & Ghosh, J. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408881200 · Cited by 216
Tanji, Y., Shimada, T., Fukudomi, H., Miyanaga, K., Nakai, Y., & Unno, H. (2005) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.100.280 · Cited by 196
Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage
López, R., & García, E. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.05.002 · Cited by 187
Therapy of Experimental Pseudomonas Infections with a Nonreplicating Genetically Modified Phage
Hagens, S., Habel, A., von Ahsen, U., von Gabain, A., & Bläsi, U. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3817-3822.2004 · Cited by 187
Human Salivary Histatins: Promising Anti-Fungal Therapeutic Agents
Tsai, H., & Bobek, L. A. (1998) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411980090040601 · Cited by 182
Heilmann, C., Hartleib, J., Hussain, M., & Peters, G. (2005) · Infection and Immunity · doi:10.1128/iai.73.8.4793-4802.2005 · Cited by 178
Nisin Biosynthesis and its Properties
Cheigh, C.-I., & Pyun, Y. (2005) · Biotechnology Letters · doi:10.1007/s10529-005-2721-x · Cited by 171
Bera, A., Biswas, R., Herbert, S., & Götz, F. (2006) · Infection and Immunity · doi:10.1128/iai.00301-06 · Cited by 171
García, P., García, J., García, E., & López, R. (1986) · Gene · doi:10.1016/0378-1119(86)90215-5 · Cited by 168
Bacterial evasion of innate host defenses – the Staphylococcus aureus lesson
Fedtke, I., Götz, F., & Peschel, A. (2004) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2004.06.016 · Cited by 157
Biotechnological exploitation of bacteriophage research
Petty, N. K., Evans, T. J., Fineran, P. C., & Salmond, G. P. C. (2006) · Trends in biotechnology · doi:10.1016/j.tibtech.2006.11.003 · Cited by 156
Reinventing phage therapy: are the parts greater than the sum?
Fischetti, V. A., Nelson, D. C., & Schuch, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1206-1508 · Cited by 155
Niyonsaba, F., & Ogawa, H. (2005) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2005.07.009 · Cited by 144
Food Safety: Human Health Hazard from Antimicrobial‐Resistant Enterococci in Animals and Food
Heuer, O. E., Hammerum, A. M., Collignon, P., & Wegener, H. C. (2006) · Clinical Infectious Diseases · doi:10.1086/507534 · Cited by 141
Dynamics of success and failure in phage and antibiotic therapy in experimental infections
Bull, J. J., Levin, B. R., DeRouin, T., Walker, N., & Bloch, C. A. (2002) · BMC Microbiology · doi:10.1186/1471-2180-2-35 · Cited by 127
Towards a comprehensive view of the bacterial cell wall
Dmitriev, B. A., Toukach, F. V., & Ehlers, S. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.10.001 · Cited by 113
Genetically modified filamentous phage as bactericidal agents: a pilot study
Hagens, S., & Bläsi, U. (2003) · Letters in Applied Microbiology · doi:10.1046/j.1472-765x.2003.01400.x · Cited by 109
Cathelicidin peptides as candidates for a novel class of antimicrobials
Zanetti, M., Gennaro, R., Skerlavaj, B., Tomasinsig, L., & Circo, R. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023395457 · Cited by 105
Antimicrobial peptides derived from hen egg lysozyme with inhibitory effect against Bacillus species
Abdou, A. M., Higashiguchi, S., Aboueleinin, A. M., Kim, M., & Ibrahim, H. R. (2005) · Food Control · doi:10.1016/j.foodcont.2005.09.010 · Cited by 103
Lytic action of cloned phi X174 gene E
Young, K. D., & Young, R. (1982) · Journal of Virology · doi:10.1128/jvi.44.3.993-1002.1982 · Cited by 99
Role of Human β-defensins in HIV Infection
Weinberg, A., Quiñones‐Mateu, M. E., & Lederman, M. M. (2006) · Advances in Dental Research · doi:10.1177/154407370601900109 · Cited by 94
Treatment of plague: promising alternatives to antibiotics
Anisimov, A. P., & Amoako, K. K. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46697-0 · Cited by 88
Masschalck, B., Deckers, D., & Michiels, C. W. (2002) · Journal of Food Protection · doi:10.4315/0362-028x-65.12.1916 · Cited by 84
Transgenic Zebrafish Expressing Chicken Lysozyme Show Resistance against Bacterial Diseases
Yazawa, R., Hırono, I., & Aoki, T. (2006) · Transgenic Research · doi:10.1007/s11248-006-0009-0 · Cited by 83
Wang, J., Hu, B., Xu, M., Yan, Q., Liu, S., Zhu, X., Sun, Z., Tao, D., Ding, L., Reed, E., et al. (2006) · PubMed · Cited by 81
Jabrane, A., Sabri, A., Compère, P., et al. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.11.5704-5710.2002 · Cited by 81
The tail lysozyme complex of bacteriophage T4
Arisaka, F., Kanamaru, S., Leiman, P. G., & Rossmann, M. G. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00098-5 · Cited by 76
Fischer, W. (2000) · Research in Microbiology · doi:10.1016/s0923-2508(00)00174-1 · Cited by 75
Veiga, P., Piquet, S., Maisons, A., Furlan, S., Courtin, P., Chapot, M.-P., & Kulakauskas, S. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05474.x · Cited by 74
Characterization of Op3, a lysis-defective mutant of bacteriophage f2
Model, P., Webster, R. E., & Zinder, N. D. (1979) · Cell · doi:10.1016/0092-8674(79)90043-6 · Cited by 65
Garcia, D. L., & Dillard, J. P. (2006) · Journal of Bacteriology · doi:10.1128/jb.00724-06 · Cited by 63
Structural Organization of the Major Autolysin from Streptococcus pneumoniae
Usobiaga, P., Medrano, F. J., Gasset, M., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6832 · Cited by 57
Kirkup, B. C. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706778773068 · Cited by 50
Mode of Action of Lactocin 160, a Bacteriocin From Vaginal Lactobacillus rhamnosus
Li, J., Aroutcheva, A. A., Faro, S., & Chikindas, M. L. (2005) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1080/10647440500148156 · Cited by 37
Virolysin: A Virus-Induced Lysin from Staphylococcal Phage Lysates.
Ralston, D. J., Baer, B. S., Lieberman, M., & Krueger, A. P. (1955) · Experimental Biology and Medicine · doi:10.3181/00379727-89-21859 · Cited by 37
Plasmid-Encoded Autolysin inBacillus anthracis: Modular Structure and Catalytic Properties
Mesnage, S., & Fouet, A. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.1.331-334.2002 · Cited by 31
Vankemmelbeke, M. N., Healy, B., Moore, G. R., Kleanthous, C., Penfold, C. N., & James, R. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.14.4900-4907.2005 · Cited by 29
On the interaction of colicin E3 with the ribosome
Zarivach, R., Ben‐Zeev, E., Wu, N., Auerbach, T., Bashan, A., Jakes, K. S., Dickman, K. R., Kosmidis, A., Schluenzen, F., Yonath, A., et al. (2002) · Biochimie · doi:10.1016/s0300-9084(02)01449-9 · Cited by 21
Kobayashi, S. (2002) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.122.967 · Cited by 5
Cited by
Ecology of zoonoses: natural and unnatural histories
Karesh, W. B., Dobson, A., Lloyd-Smith, J. O., Lubroth, J., Dixon, M. A., Bennett, M., Aldrich, S., Harrington, T., Formenty, P., Loh, E. H., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61678-x · Cited by 923
Silver Nanoparticles: Bactericidal and Mechanistic Approach against Drug Resistant Pathogens
More, P. R., Pandit, S., Filippis, A. D., Franci, G., Mijakovic, I., & Galdiero, M. (2023) · Microorganisms · doi:10.3390/microorganisms11020369 · Cited by 745
Impact of plant products on innate and adaptive immune system of cultured finfish and shellfish
Harikrishnan, R., Balasundaram, C., & Heo, M.-S. (2011) · Aquaculture · doi:10.1016/j.aquaculture.2011.03.039 · Cited by 650
Antibacterial biohybrid nanofibers for wound dressings
Homaeigohar, S., & Boccaccini, A. R. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.02.022 · Cited by 605
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields
Moretta, A., Scieuzo, C., Petrone, A. M., Salvia, R., Manniello, M. D., Franco, A., Lucchetti, D., Vassallo, A., Vogel, H., Sgambato, A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.668632 · Cited by 497
Metadata
- Authors
- Parisien, A., Allain, B., Zhang, J., Mandeville, R., & Lan, C. Q.
- Venue
- Journal of Applied Microbiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-08-02
- Volume
- 0
- Issue
- 0
- Pages
- 070802123828004-???
- ISSN
- 1364-5072 (ISSN-L)
- 1365-2672
- OpenAlex
- W1993031384
- Cited by
- 300
- References
- 78
- FWCI
- 15.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.